ST elevation myocardial infarction overview

Revision as of 20:40, 26 August 2009 by Kogando (talk | contribs)
Jump to navigation Jump to search
Myocardial infarction
ICD-10 I21-I22
ICD-9 410
DiseasesDB 8664
MedlinePlus 000195
eMedicine med/1567  emerg/327 ped/2520

WikiDoc Resources for ST elevation myocardial infarction overview

Articles

Most recent articles on ST elevation myocardial infarction overview

Most cited articles on ST elevation myocardial infarction overview

Review articles on ST elevation myocardial infarction overview

Articles on ST elevation myocardial infarction overview in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ST elevation myocardial infarction overview

Images of ST elevation myocardial infarction overview

Photos of ST elevation myocardial infarction overview

Podcasts & MP3s on ST elevation myocardial infarction overview

Videos on ST elevation myocardial infarction overview

Evidence Based Medicine

Cochrane Collaboration on ST elevation myocardial infarction overview

Bandolier on ST elevation myocardial infarction overview

TRIP on ST elevation myocardial infarction overview

Clinical Trials

Ongoing Trials on ST elevation myocardial infarction overview at Clinical Trials.gov

Trial results on ST elevation myocardial infarction overview

Clinical Trials on ST elevation myocardial infarction overview at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ST elevation myocardial infarction overview

NICE Guidance on ST elevation myocardial infarction overview

NHS PRODIGY Guidance

FDA on ST elevation myocardial infarction overview

CDC on ST elevation myocardial infarction overview

Books

Books on ST elevation myocardial infarction overview

News

ST elevation myocardial infarction overview in the news

Be alerted to news on ST elevation myocardial infarction overview

News trends on ST elevation myocardial infarction overview

Commentary

Blogs on ST elevation myocardial infarction overview

Definitions

Definitions of ST elevation myocardial infarction overview

Patient Resources / Community

Patient resources on ST elevation myocardial infarction overview

Discussion groups on ST elevation myocardial infarction overview

Patient Handouts on ST elevation myocardial infarction overview

Directions to Hospitals Treating ST elevation myocardial infarction overview

Risk calculators and risk factors for ST elevation myocardial infarction overview

Healthcare Provider Resources

Symptoms of ST elevation myocardial infarction overview

Causes & Risk Factors for ST elevation myocardial infarction overview

Diagnostic studies for ST elevation myocardial infarction overview

Treatment of ST elevation myocardial infarction overview

Continuing Medical Education (CME)

CME Programs on ST elevation myocardial infarction overview

International

ST elevation myocardial infarction overview en Espanol

ST elevation myocardial infarction overview en Francais

Business

ST elevation myocardial infarction overview in the Marketplace

Patents on ST elevation myocardial infarction overview

Experimental / Informatics

List of terms related to ST elevation myocardial infarction overview

Cardiology Network

Discuss ST elevation myocardial infarction overview further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Keywords and synonyms: AMI, STEMI, heart attack, MI, myocardial infarct, acute MI, coronary, coronary thrombosis

Overview

Acute myocardial infarction (AMI or MI), more commonly known as a heart attack, is a medical condition that occurs when the blood supply to a part of the heart muscle or myocardium is interrupted. The resulting ischemia or oxygen shortage causes damage and / or irreversible death (necrosis) of the myocardium (heart muscle). It is a medical emergency, and the leading cause of death for both men and women worldwide, particularly in developed countries.[1] The term myocardial infarction is derived from myocardium (the heart muscle) and infarction (tissue death due to oxygen starvation). The phrase "heart attack" is sometimes used incorrectly to describe sudden cardiac death, which may or may not be the result of acute myocardial infarction.

There are two types of acute MI: ST elevation myocardial infarction (STEMI), the topic of this chapter and non ST elevation MI (NSTEMI) which is discussed in another chapter of WikiDoc. ST elevation myocardial infarction refers to an electrocardiographic pattern in which the ST segments are elevated reflecting complete epicardial vessel occlusion. Once the vessel is opened by percutaneous coronary angioplasty, the ST segments can remain elevated due to absence of perfusion or flow into the myocardium itself. At this point in the evolution of the ST elevation MI, the epicardial artery is open, but the capillary network is occluded due to swelling, embolization, and / or vasospasm.

Non ST elevation myocardial infarction refers to a disease state in which the epicardial artery is open, but there is inadequate blood flow to the myocardium which results in an electrocardiographic pattern of ST segment depression. While ST elevation reflects transmural injury, ST depression may reflect ongoing subendocardial ischemia. Inadequate blood flow to the muscle may be due to embolization of material downstream into the myocardium or a restriction of blood flow due to severe narrowing of the epicardial artery. [2] [3] [4]

Epidemiology and Demographics of ST Elevation MI

Myocardial infarction is a common presentation of ischemic heart disease. The World Heart Organization (WHO) estimated in 2002 that, 12.6 percent of deaths worldwide were from ischemic heart disease. Ischemic heart disease is the leading cause of death in developed countries, but third to AIDS and lower respiratory infections in developing countries.[5] Although it is difficult to ascertain the true incidence of ST elevation myocardial infarction (STEMI), according to the ACC/AHA guidelines, a conservative estimate is that approximately 500,000 patients suffer STEMI each year [6]. The incidence of STEMI has decreased over time. In an observational study of 5,832 metropolitan patients spanning from 1975 to 1997, the incidence of STEMI decreased from 171/100,000 to 101/100,000 [7].

Risk Factors for ST Elevation Myocardial Infarction

Important ST elevation myocardial infarction risk factors are a previous history of vascular disease such as atherosclerotic coronary heart disease and/or angina, a previous heart attack or stroke, advanced age, smoking, the abuse of certain illicit drugs such as cocaine, high LDL ("Low-density lipoprotein") and low HDL ("High density lipoprotein"), diabetes, high blood pressure, obesity and family history of coronary artery disease.[8] [9]

Triggers of ST Elevation Myocardial Infarction

A trigger is an activity or environmental condition that produces short-term physiological changes that may lead directly to onset of STEMI. ST elevation myocardial infarction triggers include physical exertion, psychological stress, sexual activity, diurnal (daily) variations in cortisol and platelet aggregation and circannual (yearly) variations in lipids and infectious etiologies, exposure to pollution and or particulate matter, cocaine and ingestion of a recent fatty meal. [10]

Symptoms of ST Elevation Myocardial Infarction

One third of patients who experience ST Segment Elevation Myocardial Infarction (STEMI) will die within 24 hours of the onset of ischemia, and many of the survivors will suffer significant morbidity. Morbidity and mortality from STEMI can be reduced significantly if patients and bystanders recognize symptoms early, activate the EMS, and thereby shorten the time to definitive treatment.

Classical symptoms of acute myocardial infarction include chest pain (which in some patients may radiate to the left arm), shortness of breath, nausea, vomiting, palpitations, sweating, and anxiety or a feeling of impending doom.

Many patients will state that there was no chest pain, but rather a sense of chest discomfort that they may describe as a squeezing sensation or a sense of chest heaviness or fullness.

Patients frequently feel suddenly ill. Women may experience different symptoms from men. Common associated symptoms of MI in women include shortness of breath, weakness, and fatigue.

Serial electrocardiographic studies from the Framingham study have shown that approximately one quarter of all myocardial infarctions (the appearance of new pathologic q waves) are silent, without chest pain or other symptoms.[11] The prognosis of patients with a silent MI was as bad as those with a symptomatic MI.

Diagnostic Studies in ST Elevation Myocardial Infarction

A new clinical evidence based classification system has been jointly introduced by the American College of Cardiology (ACC), American Heart Association (AHA), European Society of Cardiology (ESC), and the World Heart Federation (WHF).[12] The primary diagnostic tests include the electrocardiogram (ECG, EKG) and blood tests to detect elevated creatine kinase or troponin levels (these are chemical markers released by damaged tissues, especially the myocardium).

Treatment of ST Elevation Myocardial Infarction

Immediate treatment for suspected acute myocardial infarction includes oxygen, full dose non-enteric coated aspirin, nitroglycerin (also known as glyceryl trinitrate) and pain relief, using an analgesic agent such morphine sulfate. Among patients who do not have signs or symptoms of cardiogenic shock, beta blocker administration has been associated with improved clinical outcomes among patients with ST elevation myocardial infarction. [13]These agents exert their benefit via several mechanisms: They reduce myocardial oxygen demands; they reduce contractility which in turn reduces the risk of mechanical complications; they reduce the risk of lethal ventricular arrhythmias.

A cornerstone in the management of STEMI is reperfusion or opening of the closed epicardial coronary artery. This can be achieved with either drugs such as a fibrinolytic agent, or mechanically with inflation of a balloon to puch the clot aside (percutaneous coronary intervention or PCI). A decade of expereince has shown that if it can be accomplished in a timely manner (a door-to-balloon time < 90 minutes), then PCI offers superior outcomes to fibrinolytic administration. In under 5% of patients, bypass surgery may be required given the extent of disease. A common practice is to perform urgent conventional balloon angioplasty of the culprit vessel as a bridge to a more definitive CABG operation.

Monitoring of the Patient to Reduce post MI Complications

Admission of patients to the modern coronary care unit has been associated with rapid treatment of and reduced complications from fatal arrhythmias such as ventricular tachycardia or ventricular fibrillation.

Other complications of STEMI include reinfarction, infarct extension, postinfarction angina,rupture of the ventricular septum causing a ventricular septal defect, acute mitral regurgitation, myocardial rupture, development of a pseudoaneurysm, development of cardiogenic shock, development of a ventricular aneurysm, embolic complications, and pericarditis

Prognosis

Despite advances in modern pharmacotherapy and device-based therapy, the short term mortality remains high in modern registry series (15%-20%). The prognosis for patients with myocardial infarction varies greatly depending upon simple demographic variables like age, the presence of signs and symptoms of heart failure, the duration of symptoms, and comorbidities that are present. Several risk stratification tools have been developed to predict a patient's mortality. Most of these risk scores are based upon clinical data obtained at the time of admission rather than at the time of discharge.

While we as physicians often labor under the impression that we can dramatically change a patient's prognosis, it is noteworthy that 90% of the predictive information regarding 30 day mortality is contained in the following 5 baseline variables that can be modified to only a limited degree: [14]

  1. Advanced age
  2. Sinus tachycardia
  3. Reduced systolic blood pressure
  4. Heart failure or Killip class of two or greater
  5. Anterior myocardial infarction location

Sinus tachycardia, hypotension, Killip class, and anterior MI are all essentially markers of poor pump function on admission. These risk factors for 30 day mortality have been well validated in a multivariate analysis of 41,020 patients in the GUSTO-I trial. Advanced age was the most significant factor associated with higher 30-day mortality. The rate was only 1.1% in the youngest decile (< 45 years) and climbed to 20.5% in patients > 75 (adjusted chi 2 = 717, P < .0001). Other variables most closely associated with an increased risk of mortality were lower systolic blood pressure at randomizaiton (chi 2 = 550, P < .0001), higher Killip class (chi 2 = 350, P < .0001), elevated heart rate (chi 2 = 275, P < .0001), and the presence of an anterior infarction (chi 2 = 143, P < .0001). When taken together, these five baseline characteristics contained 90% of the prognostic information. Other significant though less important factors included previous myocardial infarction, height, time to treatment, diabetes, weight, smoking status, type of thrombolytic, previous bypass surgery, hypertension, and prior cerebrovascular disease. When these variables were combined, a validated model was created which stratified patients according to their mortality risk and accurately estimated the likelihood of death.

Various risk tools such as the GRACE risk score have been developed to risk stratify patients.

Sources

  • The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [15]
  • The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [16]

References

  1. The World Health Report 2004 - Changing History (PDF). World Health Organization. 2004. pp. 120–4. ISBN 92-4-156265-X.
  2. Hurst’s The Heart, Fuster V, 12th edition, 2008
  3. Topol’s Textbook of Cardiovascular Medicine, Topol E, 3rd edition, 2007
  4. Mayo Textbook of Cardiology, 2007
  5. "Cause of Death - UC Atlas of Global Inequality". Center for Global, International and Regional Studies (CGIRS) at the University of California Santa Cruz. Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |accessmonthday= ignored (help)
  6. Antman EM, Anbe DT, Armstrong PW; et al. (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction)". J. Am. Coll. Cardiol. 44 (3): E1–E211. doi:10.1016/j.jacc.2004.07.014. PMID 15358047. Unknown parameter |month= ignored (help)
  7. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM (2001). "Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective". J. Am. Coll. Cardiol. 37 (6): 1571–80. PMID 11345367. Unknown parameter |month= ignored (help)
  8. Antman EM, Anbe DT, Armstrong PW; et al. (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)". Circulation. 110 (5): 588–636. doi:10.1161/01.CIR.0000134791.68010.FA. PMID 15289388. Unknown parameter |month= ignored (help)
  9. Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 51 (2): 210–47. doi:10.1016/j.jacc.2007.10.001. PMID 18191746. Unknown parameter |month= ignored (help)
  10. Muller JE, Abela GS, Nesto RW, Tofler GH (1994). "Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier". J. Am. Coll. Cardiol. 23 (3): 809–13. PMID 8113568. Unknown parameter |month= ignored (help)
  11. Kannel WB (1986). "Silent myocardial ischemia and infarction: insights from the Framingham Study". Cardiol Clin. 4 (4): 583–91. PMID 3779719. Unknown parameter |month= ignored (help)
  12. Thygesen K, Alpert JS, White HD (2007). "Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Joint ESC/ACCF/AHA/WHF". Circulation. 2007: 2634–2653. PMID 17951284.
  13. Dargie HJ (2001). "Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial". Lancet. 357 (9266): 1385–90. PMID 11356434. Unknown parameter |month= ignored (help)
  14. Lee KL, Woodlief LH, Topol EJ; et al. (1995). "Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators". Circulation. 91 (6): 1659–68. PMID 7882472. Unknown parameter |month= ignored (help)
  15. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation. 110 (9): e82–292. PMID 15339869. Unknown parameter |month= ignored (help)
  16. Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)

External links



Template:WikiDoc Sources